Chordia Therapeutics Inc. (190A) — research page
JP · jp-cm-kg/TSE-GROWTH/190A · as of 2026-11-06
Identity and listing
The issuer is Chordia Therapeutics Inc., listed on the Growth Market, with ticker 190A. The ISIN is not on the record and the LEI is not on the record. The security type is Corporate. The segment is not on the record. The sector is 3250 Pharmaceutical. The jurisdiction is Japan (EDINET domestic filer). The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Chordia Therapeutics Inc. | source · 2026-11-06 |
| exchange | Growth Market | source · 2026-11-06 |
| ticker | 190A | source · 2026-11-06 |
| ISIN | not on the record | |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | 3250 Pharmaceutical | source · 2026-11-06 |
| jurisdiction | Japan (EDINET domestic filer) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 8 filings across 5 filing days in the twelve months to 2026-11-06. The filings comprise 2 ad hoc, 1 prospectus, 3 regulatory filings and 2 results. The median gap between filing days is 69.5 days. The latest filing is dated 2026-08-24 and is a prospectus, 74 days before the record date. On the Growth Market the median cadence gap is 42 days across 598 issuers, the median filing count is 8.0, and the median latency is 85.0 days. On 3250 Pharmaceutical the median cadence gap is 49.5 days across 80 issuers, the median filing count is 8.0, and the median latency is 85.0 days.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 8 | 69.5 | 74 |
| exchange median: Growth Market (598 issuers) | 8 | 42 | 85 |
| sector median: 3250 Pharmaceutical (80 issuers) | 8 | 49.5 | 85 |
| date | type | category | filing |
|---|---|---|---|
| 2026-08-24 | prospectus | 有価証券届出書 (securities registration statement) | 有価証券届出書（参照方式） |
| 2026-04-14 | regulatory_filing | 135 | 確認書 |
| 2026-04-14 | results | 半期報告書 (half-year report) | 半期報告書－第9期(2025/09/01－2026/08/31) |
| 2026-02-20 | ad_hoc | 臨時報告書 (extraordinary report) | 臨時報告書 |
| 2025-11-26 | ad_hoc | 臨時報告書 (extraordinary report) | 臨時報告書 |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is 有限責任 あずさ監査法人. The location of the auditor is not on the record. The auditor changes are not on the record, as the market's record does not carry a lifecycle type map for this register.
Events and halts
The listing, delisting, name change, domicile change and segment move lines are not on the record, as the index does not carry a lifecycle type for this market. The issuer is listed and not halted.
Orderability
For the client category Qualified Institutional Investors the outcome is not determinable. The rule states a product scope, the issuer's class carries no CFI to place on the scope bridge, and no scope object names the class, so the issuer is not shown within the scope. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, with the chapter as of 2026-11-04.
| client category | outcome |
|---|---|
| Qualified Institutional Investors | not determinable: the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope |
rule acm-68000/jp/suitability-principle-fiea-article-40/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations page as read. The count is 0.
Open research
One openly published research note is on the record, published by FISCO Ltd. on 2025-12-12.
| date | publisher | note | kind |
|---|---|---|---|
| 2025-12-12 | FISCO Ltd. | COMPANY RESEARCH AND ANALYSIS REPORT Chordia Therapeutics Inc. | issuer-sponsored |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed. The market's earliest sealed date is not on the record, and the live record began is not on the record.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
- 10.2
- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
- 10.3
- https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/190A (the disclosure lines)
- 10.4
- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
- 10.5
- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100X63V (the auditor)
- 10.6
- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.7
- https://www.chordiatherapeutics.com/en/ir/library/report/main/011115/teaserItems1/04/linkList/0/link/20251212_report.pdf (open research)
- 10.8
- https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/190A (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"190A","exchange":"Growth Market"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:38ca78fa2b078609.